Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: What should clinicians measure?*

Journal of the American College of Cardiology

Volumn 60, Issue 25, 2012, Pages 2616-2617

  Davidson, Michael H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

analysis; apolipoprotein B; clinical; lipoprotein

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B100; APOLIPOPROTEIN C3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; HUMAN; LIPID ANALYSIS; NOTE; PREDICTION; PRIORITY JOURNAL;

EID: 84871292561     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.06.065     Document Type: Editorial

References (10)

1. J.G. Robinson What is the role of advanced lipoprotein analysis in practice? J Am Coll Cardiol 60 2012 2607 2615
2. J.D. Brunzell, M. Davidson, C.D. Furberg Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524 (Pubitemid 351470037)
3. M.H. Davidson, C.M. Ballantyne, T.A. Jacobson Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists J Clin Lipidol 5 2011 338 367
4. F.M. Sacks, P. Alaupovic, L.A. Moye VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial Circulation 102 2000 1886 1892
5. T. Mazzone, P.M. Meyer, G.T. Kondos Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes Diabetes 56 2007 849 855 (Pubitemid 46348462)
6. S.M. Boekholdt, B.J. Arsenault, S. Mora Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis JAMA 307 2012 1302 1309
7. S.S. Virani, L. Steinberg, T. Murray Barriers to non-HDL cholesterol goal attainment by providers Am J Med 124 2011 876 880.e2
8. J. Danesh The Emerging Risk Factors Collaboration Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
9. A.D. Sniderman, K. Williams, M.J. McQueen, C.D. Furberg When is equal not equal? J Clin Lipidol 4 2010 83 88
10. W.C. Cromwell, J.D. Otvos, M.J. Keyes LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-implications for LDL management J Clin Lipidol 1 2007 583 592 (Pubitemid 350215511)